Primary and rescue percutaneous coronary intervention with paclitaxel-eluting stent implantation in ST-elevation myocardial infarction.
We conducted a retrospective comparison of paclitaxel-eluting stents (PESs, n = 60) versus bare metal stents (BMSs, n = 137) in consecutive patients who underwent primary or rescue percutaneous coronary intervention over 1 year. The PES cohort had no in-stent thromboses and had a 65% (p = 0.02) decrease in the combined end point of death, recurrent myocardial infarction, and target vessel revascularization at 1 year compared with the BMS group. PES implantation appears to be safe and possibly superior to BMS implantation in terms of 1-year major cardiovascular outcomes in the setting of ST-elevation myocardial infarction.
Schwalm
Jon-David Reid
JD
The Department of Medicine, Division of Cardiology, Hamilton General Hospital Site, McMaster University, Hamilton, Ontario, Canada. schwalj@mcmaster.ca
Ahmad
Mayraj
M
Velianou
James L
JL
Xie
Changchun
C
Natarajan
Madhu K
MK
D015906:Angioplasty, Balloon, Coronary; D002170:Canada / Q000453:epidemiology; D003328:Coronary Thrombosis / Q000453:epidemiology; D016503:Drug Delivery Systems; D004562:Electrocardiography; D005260:Female; D017052:Hospital Mortality; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000401:mortality / Q000628:therapy*; D009204:Myocardial Revascularization; D017239:Paclitaxel / Q000008:administration & dosage*; D012189:Retrospective Studies; D015607:Stents; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D017239:Paclitaxel